Capital Bank & Trust CO Allogene Therapeutics, Inc. Transaction History

Capital Bank & Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$21.01 - $27.64 $2.46 Million - $3.23 Million	-116,948 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$23.49 - $35.8 $82,402 - $125,586	-3,508 Reduced 2.91%	116,948 $3.05 Million
Q1 2021 May 14, 2021	SELL	$25.79 - $39.02 $82,682 - $125,098	-3,206 Reduced 2.59%	120,456 $4.25 Million
Q4 2020 Feb 16, 2021	SELL	$25.24 - $43.45 $487,813 - $839,758	-19,327 Reduced 13.52%	123,662 $3.12 Million
Q3 2020 Nov 13, 2020	BUY	$32.38 - $44.96 $127,868 - $177,547	3,949 Added 2.84%	142,989 $5.39 Million

Q2 2020 Aug 14, 2020	BUY	$18.39 - $54.04 $2.56 Million - $7.51 Million	139,040 New	139,040 $5.95 Million

164

106M

97.5K

45.6K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $305M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Capital Bank & Trust CO with notifications on news.